Avadel Pharmaceuticals is a drug manufacturers-specialty & generic business based in the US. Avadel Pharmaceuticals shares (AVDL) are listed on the NASDAQ and all prices are listed in US Dollars. Avadel Pharmaceuticals employs 41 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Avadel Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AVDL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Avadel Pharmaceuticals stock price (NASDAQ: AVDL)
Use our graph to track the performance of AVDL stocks over time.Avadel Pharmaceuticals shares at a glance
Latest market close | $13.84 |
---|---|
52-week range | $1.05 - $15.82 |
50-day moving average | $10.90 |
200-day moving average | $8.02 |
Wall St. target price | $16.45 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.37 |
Buy Avadel Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Avadel Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avadel Pharmaceuticals price performance over time
Historical closes compared with the close of $13.84 from 2023-05-26
1 week (2023-05-19) | -2.95% |
---|---|
1 month (2023-04-28) | 32.06% |
3 months (2023-02-28) | 39.10% |
6 months (2022-11-28) | 74.09% |
1 year (2022-05-27) | 453.60% |
---|---|
2 years (2021-05-28) | 79.97% |
3 years (2020-05-28) | 73.87% |
5 years (2018-05-25) | 105.04% |
Is Avadel Pharmaceuticals stock undervalued or overvalued?
Valuing Avadel Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avadel Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avadel Pharmaceuticals's PEG ratio
Avadel Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Avadel Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Avadel Pharmaceuticals financials
Gross profit TTM | $16.6 million |
---|---|
Return on assets TTM | -31.32% |
Return on equity TTM | -481.49% |
Profit margin | 0% |
Book value | $-0.34 |
Market capitalisation | $1.1 billion |
TTM: trailing 12 months
Avadel Pharmaceuticals share dividends
We're not expecting Avadel Pharmaceuticals to pay a dividend over the next 12 months.
Avadel Pharmaceuticals share price volatility
Over the last 12 months, Avadel Pharmaceuticals's shares have ranged in value from as little as $1.05 up to $15.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avadel Pharmaceuticals's is 1.4339. This would suggest that Avadel Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avadel Pharmaceuticals overview
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. .
Avadel Pharmaceuticals in the news
Independent Director of Avadel Pharmaceuticals Picks Up 8.4% More Stock \
Why Shares of Avadel Soared This Week
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
Frequently asked questions
What percentage of Avadel Pharmaceuticals is owned by insiders or institutions?Currently 5.215% of Avadel Pharmaceuticals shares are held by insiders and 45.167% by institutions. How many people work for Avadel Pharmaceuticals?
Latest data suggests 41 work at Avadel Pharmaceuticals. When does the fiscal year end for Avadel Pharmaceuticals?
Avadel Pharmaceuticals's fiscal year ends in December. Where is Avadel Pharmaceuticals based?
Avadel Pharmaceuticals's address is: 10 Earlsfort Terrace, Dublin, Ireland, 2 What is Avadel Pharmaceuticals's ISIN number?
Avadel Pharmaceuticals's international securities identification number is: US05337M1045 What is Avadel Pharmaceuticals's CUSIP number?
Avadel Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 338488109
More guides on Finder
-
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
-
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
-
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
-
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
-
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
Best online brokers & platforms to buy gold stocks in May 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert